PT  - JOURNAL ARTICLE
AU  - Gingher, Erin L.
AU  - Fruhauf, Timothee F.
AU  - Sao, Saumya S.
AU  - Wang, Runzhi
AU  - Coleman, Jenell S.
TI  - Shifting PrEP Initiation from Practitioner to Nurse: a clinic-level multi-modal intervention protocol to increase PrEP uptake among women at increased risk of HIV acquisition in a U.S. OB/GYN clinical setting
AID  - 10.1101/2022.07.14.22277560
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.07.14.22277560
4099  - http://medrxiv.org/content/early/2022/07/17/2022.07.14.22277560.short
4100  - http://medrxiv.org/content/early/2022/07/17/2022.07.14.22277560.full
AB  - Women comprise 20% of new HIV diagnoses in the U.S. with 86% attributed to heterosexual contact, but HIV pre-exposure prophylaxis (PrEP) uptake is low. OB/GYN clinics are ideal settings to increase HIV prevention counseling for cisgender women, as patients are more likely to discuss their sexual behavior, undergo sexually transmitted infection screening, and receive risk reduction counseling. Our study will assess the feasibility, acceptability, and effectiveness of a registered nurse (RN)-led PrEP project in OB/GYN clinics. Microlearning and Plan-Do-Study-Act cycles will be performed, followed by a randomized controlled trial (RCT). A total of cisgender women determined to be at-risk for HIV will be randomized to standard of care with electronic medical record enhancements (e-SOC) or e-SOC with contact and PrEP counselling by an RN, who will be able to prescribe PrEP under protocol guidance. By shifting HIV PrEP counselling to a nurse, clinics may be able to increase PrEP awareness and uptake.Registered with clinicaltrials.gov: NCT05095818Competing Interest StatementE.G. and J.C. were funded in part by Gilead Sciences. The remaining authors report no financial interests or potential conflicts of interest.Clinical TrialNCT05095818Funding StatementE.G. and J.C. were funded in part by Gilead Sciences.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics committee/IRB of Johns Hopkins Medicine gaive ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis paper contains no data as it is a clinical trial protocol.